We're not in it for the money-lay people's moral intuitions on commercial use of 'their' biobank

Medicine, Health Care and Philosophy

Volumn 16, Issue 2, 2013, Pages 151-162

  Steinsbekk, Kristin Solum ^a   Ursin, Lars Øystein ^b   Skolbekken, John Arne ^b   Solberg, Berge ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Benefit sharing; Biobanking; Commercialisation; Commodification; Focus group research; Lay perspective

Indexed keywords

EID: 84876053303     PISSN: 13867423     EISSN: 15728633     Source Type: Journal    
DOI: 10.1007/s11019-011-9353-9     Document Type: Article

References (61)

1. Andrews, L., and D. Nelkin. 2001. Body bazaar: The market for human tissue in the biotechnology age. New York: Crown Publications.
2. Brice, P. 2009. New funding for UK and Chinese biobanks. PHG foundation. http://www. phgfoundation. org/news/4765/. Accessed 11 May 2011.
3. CGM Riken. 2011. The BioBank Japan project on the implementation of personalized medicine. http://www. src. riken. jp/english/project/person/index. html. Accessed 11 May 2011.
4. Cookson, C. 2010. Germany plans mass medical study. Financial times, ft. com. http://www. ft. com/cms/s/0/7f7c8190-8793-11df-9f37-00144feabdc0. html#axzz1KdFszze1. Accessed 26 Apr 2011.
5. Council of Europe. 1997. Oviedo convention: Convention on human rights and biomedicine. http://conventions. coe. int/Treaty/en/Treaties/Html/164. htm. Accessed 29 May 2011.
6. Council of Europe. 2006. Rec(2006)4 recommendation on research on biological materials of human origin. https://wcd. coe. int/wcd/ViewDoc. jsp?id=977859. Accessed 29 May 2011.
7. Dawson, A. 2010. The future of bioethics: Three dogmas and a cup of hemlock. Bioethics 24(5): 218-225.
8. Dinamo. 2011. Edelman trust barometer. Norwegian findings. Dinamo. no. http://www. scribd. com/full/47667236?access_key=key-2axeq5u99rj6dxgi9jt8. Accessed 16 June 2011.
9. Fugelsnes, E. 2009. Vil hente fram forskningsgullet. [Will retrieve the research gold]. Forskning. no. http://www. forskning. no/artikler/2009/februar/209050. Accessed 24 Sept 2010.
10. Gaskell, G., and H. Gottweis. 2011. Biobanks need publicity. Nature 471(7337): 159-160.
11. Godard, B., Schmidtke, J., Cassiman, J.-J., and Aymé, S. 2003. Data storage and DNA banking for biomedical research: Informed consent, confidentiality, quality issues, ownership, return of benefits. A professional perspective. European Journal of Human Genetics: EJHG 11(Suppl 2): S88-S122.
12. Haddow, G., G. Laurie, S. Cunningham-Burley, and K. G. Hunter. 2007. Tackling community concerns about commercialisation and genetic research: A modest interdisciplinary proposal. Social Science and Medicine 64(2): 272-282.
13. Haimes, E. 2002. What can the social sciences contribute to the study of ethics? Theoretical, empirical and substantive considerations. Bioethics 16(2): 89-113.
14. Hall, S. 2006. £61 m medical experiment begins. guardian. co. uk. http://www. guardian. co. uk/science/2006/aug/22/medicineandhealth. lifeandhealth. Accessed 11 May 2011.
15. Healy, K. 2004. Sacred markets and secular ritual in the organ transplant industry. In The sociology of the economy, ed. F. Dobbin, 308-333. New York: Russell Sage Foundation.
16. Hoeyer, K. 2004. Ambiguous gifts: public anxiety, informed consent and biobanks. In Genetic databases. Socio-ethical issues in the collection and use of DNA, ed. O. Corrigan, and R. Tutton, 97-116. London: Routledge.
17. Hoeyer, K. 2005. The role of ethics in commercial genetic research: Notes on the notion of commodification. Medical Anthropology 24(1): 45-70.
18. Hoeyer, K. 2007. Person, patent and property: A critique of the commodification hypothesis. BioSocieties 2(3): 327-348.
19. Hoeyer, K., and N. Lynöe. 2006. Motivating donors to genetic research? Anthropological reasons to rethink the role of informed consent. Medicine, Health Care and Philosophy 9(1): 13-23.
20. Holland, S. 2001. Contested commodities at both ends of life: buying and selling gametes, embryos, and body tissues. Kennedy Institute of Ethics Journal 11(3): 263-284.
21. HUNT Biosciences. 2011. Homepage HUNT Biosciences. http://www. huntbiosciences. com/. Accessed 21 March 2011.
22. Irish Council for Bioethics. 2005. Human biological material: Recommendations for collection, use and storage in research. http://www. bioethics. ie/index. php/human-biological-material-for-research. Accessed 13 Apr 2011.
23. Kass, L. R. 1997. The wisdom of repugnance. The New Republic216(22). http://www. catholiceducation. org/articles/medical_ethics/me0006. html. Accessed 8 June 2011.
24. Kettis-Lindblad, A., L. Ring, E. Viberth, and M. G. Hansson. 2006. Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think? European Journal of Public Health 16(4): 433-440.
25. Kierulf, P. 2006. Biobank(ing): Thoughts on practical guidelines for collecting material for biomarkers. Norwegian Journal of Epidemiology 16(1): 51-52.
26. Krueger, R. A. 1998. Analyzing and reporting focus group results. Thousands Oaks: SAGE Publication Ltd.
27. Kuras, A. 2010. Michigan Biotrust for Health spots opportunities in blood research. Research Corridor Micigan's URC. http://researchcorridor. com/features/michiganneonatalbiobank0003. aspx. Accessed 11 May 2011.
28. Lenk, C., and Beier, K. 2011. Is the commercialisation of human tissue and body material forbidden in the countries of the European Union? Journal of Medical Ethics. Online first 22 June 2011. doi: 10. 1136/jme. 2010. 038760.
29. Malterud, K. 2003. Kvalitative metoder i medisinsk forskning. [Qualitative methods in medical research]. Oslo: Universitetsforlaget.
30. Ministry of Health and Care Services. 2001. NOU 2001: 19. Biobanker Innhenting, oppbevaring, bruk og destruksjon av humant biologisk materiale. [Biobanks. The procurement, storage, use and destruction of human biological material]. http://www. regjeringen. no/Rpub/NOU/20012001/019/PDFA/NOU200120010019000DDDPDFA. pdf.
31. Ministry of Health and Care Services. 2008. Act on medical and health research (the Health Research Act). http://www. regjeringen. no/upload/HOD/HRA/Helseforskning/Helseforskningsloven%20-%20ENGELSK%20endelig%2029%2006%2009. pdf.
32. Morgan, D. 1993. Successful focus groups: Advancing the state of the art, 1st ed. Thousands Oaks: SAGE Publication Ltd.
33. Nicol, D., and Critchley, C. 2011. Benefit sharing and biobanking in Australia. Public understanding of science. doi: 10. 1177/0963662511402425.
34. Nilstun, T., and G. Hermerén. 2006. Human tissue samples and ethics. Medicine, Health Care and Philosophy 9(1): 81-86.
35. NTNU. 2011a. The Nord-Trøndelag health study. http://www. ntnu. edu/hunt, Accessed 25 May 2011.
36. NTNU. 2011b. HUNT Biobank. Det medisinske fakultet. http://www. ntnu. no/hunt/biobank. Accessed 27 May 2011.
37. NTNU. 2011c. HUNT Biosciences AS. http://www. ntnu. no/hunt/biosciences. Accessed 4 June 2011.
38. NTNU. 2011d. HUNT: En av verdens største helseundersøkelser. [One of the worlds largest health studies]. http://www. ntnu. no/hunt/screening. Accessed 30 April 2009.
39. Palsson, G. 2008. The rise and fall of a biobank. In Biobanks: governance in comparative perspective, ed. H. Gottweis, and A. R. P. D. Petersen, 41-55. London: Routledge.
40. Policy and Medicine. 2011. NEJM the private sector discoveries account for 79-90% of pharmaceutical products. http://www. policymed. com/2011/02/nejm-the-private-sector-discoveries-account-for-79-90-of-pharmaceutical-products. html. Accessed 26 June 2011.
41. Research Council of Norway. 2008. Gode biobanker-Bedre helse. [Good biobanks-Better health]. Forskningsrådet. Oslo. http://www. forskningsradet. no/en/Home_page/1177315753906.
42. Research Council of Norway. 2010. Potensial for kommersiell utnyttelse av humane biobanker. [The potential for commercial utilisation of human biobanks]. Forskningsrådet. Oslo. http://www. forskningsradet. no/en/Home_page/1177315753906.
43. Roel, J. E. 2011. Bio i banken er gull verdt [Bio in the bank has gold worht]. Adresseavisen, March 12th: 14-18. Trondheim, Norway.
44. Rose, H. 2006. From Hype to mothballs in four years: Troubles in the development of large-scale DNA biobanks in Europe. Public Health Genomics 9(3): 184-189.
45. Rothman, S. M., and D. J. Rothman. 2006. The hidden cost of organ sale. American Journal of Transplantation 6(7): 1524-1528.
46. Schweda, M., and S. Schicktanz. 2009. Public ideas and values concerning the commercialization of organ donation in four European countries. Social Science and Medicine 68(6): 1129-1136.
47. Seale, C., D. Cavers, and M. Dixon-Woods. 2006. Commodification of body parts: By medicine or by media? Body and Society 12(1): 25-42.
48. Sharp, L. A. 2000. The commodification of the body and its parts. Annual Review of Anthropology 29(1): 287-328.
49. Sharp, L. A. 2009. Bodies, commodities, and biotechnologies: Death, mourning, and scientific desire in the realm of human organ transfer. New York: Columbia University Press.
50. Skolbekken, J.-A., L.Ø. Ursin, B. Solberg, E. Christensen, et al. 2005. Not worth the paper it's written on? Informed consent and biobank research in a Norwegian context. Critical Public Health 15: 335-347.
51. Stegmayr, B., and K. Asplund. 2002. Informed consent for genetic research on blood stored for more than a decade: a population based study. BMJ 325(7365): 634-635.
52. Steinsbekk, K. S., B. Solberg, and B. K. Myskja. 2009. From idealism to realism: Commercial ventures in publicly funded biobanks. In New challenges for biobanks: Ethics, law and governance (GeneBanC project, ed. K. Dierickx, and P. Borry, 137-151. Antwerp: Intersentia.
53. Taylor, C. 1985. Philosophical papers: Volume 1, human agency and language (Philosophical papers, Vol 1). Cambridge: Cambridge University Press.
54. Thomas, C. M. (2006). A framework for the collection retention and use of human body parts. Doctoral thesis. Victoria University of Wellington, Wellington, New Zealand. http://researcharchive. vuw. ac. nz/bitstream/handle/10063/297/thesis. pdf?sequence=2. Accessed 24 June 2011.
55. Trinidad, S. B., S. M. Fullerton, J. M. Bares, G. P. Jarvik, et al. 2010. Genomic research and wide data sharing: views of prospective participants. Genetics in Medicine: Official Journal of the American College of Medical Genetics 12(8): 486-495.
56. Tupasela, A., S. Sihvo, K. Snell, P. Jallinoja, et al. 2010. Attitudes towards biomedical use of tissue sample collections, consent, and biobanks among Finns. Scandinavian Journal of Public Health 38(1): 46-52.
57. UK Biobank. (2007). UK biobank ethics and governance framework (No. 3). UK Biobank. http://www. ukbiobank. ac. uk/docs/EGF20082. pdf.
58. UK Biobank. 2009. UK biobank home page. http://www. ukbiobank. ac. uk/.
59. Ursin, L.Ø. 2010. Biobank research and the welfare state project: the HUNT-story. Critical Public Health 20(4): 453.
60. Walsh, F. 2010. DNA bank hits goal of enrolling half a million adults. BBC News 7 July 2010. http://www. bbc. co. uk/news/10544498. Accessed 26 April 2011.
61. Webster, A., Brown, N., Douglas, C., Graham, L., et al. 2008. Public attitudes to third party access and benefit sharing: Their application to UK Biobank. Final report. Science and Technology Studies Unit (SATSU) University of York. http://www. egcukbiobank. org. uk/assets/wtx052208. pdf.